The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho

Journal of Leukocyte Biology

Volumn 75, Issue 6, 2004, Pages 1173-1182

  Pfeiffer, Zachary A ^a   Aga, Mini ^a   Prabhu, Usha ^a   Watters, Jyoti J ^a,b   Hall, David J ^a,c   Bertics, Paul J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c LAWRENCE UNIVERSITY   (United States)

Author keywords

Cytoskeleton; Inflammation; Mitogen activated protein kinases

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 3' O (4 BENZOYLBENZOYL)ADENOSINE TRIPHOSPHATE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIN; ADENOSINE TRIPHOSPHATE; INHIBITOR PROTEIN; ION CHANNEL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PURINE P2X7 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; RHO FACTOR;

ANIMAL CELL; ARTICLE; CHANNEL GATING; CYTOKINE RELEASE; CYTOSKELETON; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; MACROPHAGE; MACROPHAGE FUNCTION; MEMBRANE STRUCTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOSINE TRIPHOSPHATE; AMIDES; ANIMALS; CELL MEMBRANE; CYTOCHALASIN D; CYTOSKELETON; ENZYME ACTIVATION; ENZYME INHIBITORS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MICE; MICROFILAMENTS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEIC ACID SYNTHESIS INHIBITORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET AGGREGATION INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; RECEPTORS, PURINERGIC P2;

ANIMALIA;

EID: 2642512455     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1203648     Document Type: Article

References (55)

1. Chiozzi, P., Sanz, J. M., Ferrari, D., Falzoni, S., Aleotti, A., Buell, G. N., Collo, G., Di Virgilio, F. (1997) Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor. J. Cell Biol. 138, 697-706.
2. la Sala, A., Ferrari, D., Di Virgilio, F., Idzko, M., Norgauer, J., Girolomoni, G. (2003) Alerting and tuning the immune response by extracellular nucleotides. J. Leukoc. Biol. 73, 339-343.
3. North, R. A. (2002) Molecular physiology of P2X receptors. Physiol. Rev. 82, 1013-1067.
4. Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., Buell, G. (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272, 735-738.
5. Di Virgilio, F. (1995) The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today 16, 524-528.
6. Watters, J., Sommer, J., Fisette, P., Pfeiffer, Z., Aga, M., Prabhu, U., Guerra, A., Denlinger, L., Bertics, P. (2001) P2X7 nucleotide receptor: Modulation of LPS-induced macrophage signaling and mediator production. Drug Dev. Res. 53, 91-104.
7. Aga, M., Johnson, C. J., Hart, A. P., Guadarrama, A. G., Suresh, M., Svaren, J., Bertics, P, J., Darien, B. J. (2002) Modulation of monocyte signaling and pore formation in response to agonists of the nucleotide receptor P2X(7). J. Leukoc. Biol. 72, 222-232.
8. Hu, Y., Fisette, P. L., Denlinger, L. C., Guadarrama, A. G., Sommer, J, A., Proctor, R. A., Bertics, P. J, (1998) Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J. Biol. Chem. 273, 27170-27175.
9. Janmey, P, A. (1998) The cytoskeleton and cell signaling: component localization and mechanical coupling. Physiol. Rev. 78, 763-781.
10. Tapper, H. (1996) The secretion of preformed granules by macrophages and neutrophils. J. Leukoc. Biol. 59, 613-622.
11. Jones, G. E. (2000) Cellular signaling in macrophage migration and chemotaxis, J. Leukoc. Biol. 68, 593-602.
12. Denlinger, L. C., Fisette, P. L., Sommer, J. A., Watters, J. J., Prabhu, U., Dubyak, G, R., Proctor, R. A., Bertics, P. J. (2001) Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J. Immunol. 167, 1871-1876.
13. Denlinger, L. C., Sommer, J. A., Parker, K., Gudipaty, L., Fisette, P. L., Watters, J. W., Proctor, R. A., Dubyak, G. R., Bertics, P. J. (2003) Mutation of a dibasic amino acid motif within the C terminus of the P2X7 nucleotide receptor results in trafficking defects and impaired function. J. Immunol. 171, 1304-1311.
14. Smart, M. L., Gu, B., Panchal, R. G., Wiley, J., Cromer, B., Williams, D. A., Petrou, S. (2003) P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J. Biol. Chem. 278, 8853-8860.
15. Kim, M., Jiang, L. H., Wilson, H. L., North, R. A., Surprenant, A. (2001) Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J. 20, 6347-6358.
16. Schmidt, A., Hall, M. N. (1998) Signaling to the actin cytoskeleton. Annu. Rev. Cell Dev. Biol. 14, 305-338.
17. Virginio, C., MacKenzie, A., North, R. A., Surprenant, A. (1999) Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J. Physiol. 519, 335-346.
18. Ferrari, D., La Sala, A., Chiozzi, P., Morelli, A., Falzoni, S., Girolomoni, G., Idzko, M., Dichmann, S., Norgauer, J., Di Virgilio, F. (2000) The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J. 14, 2466-2476.
19. Verhoef, P. A., Estacion, M., Schilling, W., Dubyak, G. R. (2003) P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1β release. J. Immunol. 170, 5728-5738.
20. Perregaux, D., Gabel, C. A. (1994) Interleukin-1 β maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269, 15195-15203.
21. Hagmann, J., Burger, M. M., Dagan, D. (1999) Regulation of plasma membrane blebbing by the cytoskeleton. J. Cell. Biochem. 73, 488-499.
22. Torgerson, R. R., McNiven, M. A. (1998) The actin-myosin cytoskeleton mediates reversible agonist-induced membrane blebbing. J. Cell Sci. 111, 2911-2922.
23. Kanthou, C., Tozer, G. M. (2002) The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells. Blood 99, 2060-2069.
24. Morelli, A., Chiozzi, P., Chiesa, A., Ferrari, D., Sanz, J. M., Falzoni, S., Pinton, P., Rizzuto, R., Olson, M. F., Di Virgilio, F. (2003) Extracellular ATP causes ROCK I-dependent bleb formation in P2X7-transfected HEK293 cells. Mol. Biol. Cell 14, 2655-2664.
25. Khakh, B. S., Burnstock, G., Kennedy, C., King, B. F., North, R. A., Seguela, P., Voigt, M., Humphrey, P. P. (2001) International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol. Rev. 53, 107-118.
26. Cooper, J. A. (1987) Effects of cytochalasin and phalloidin on actin. J. Cell Biol. 105, 1473-1478.
27. Smart, M. L., Panchal, R. G., Bowser, D. N., Williams, D. A., Petrou, S. (2002) Pore formation is not associated with macroscopic redistribution of P2X7 receptors. Am. J. Physiol. Cell Physiol. 283, C77-C84.
28. Wilson, K. P., McCaffrey, P. G., Hsiao, K., Pazhanisamy, S., Galullo, V., Bemis, G. W., Fitzgibbon, M. J., Caron, P. R., Murcko, M. A., Su, M. S. (1997) The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chem. Biol. 4, 423-431.
29. Armstrong, S. C., Delacey M., Ganote, C. E. (1999) Phosphorylation state of hsp27 and p38 MAPK during preconditioning and protein phosphatase inhibitor protection of rabbit cardiomyocytes. J. Mol. Cell. Cardiol. 31, 555-567.
30. Watters, J. J., Sommer, J. A., Pfeiffer, Z. A., Prabhu, U., Guerra, A. N., Bertics, P. J. (2002) A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: the MEK/ERK pathway is not essential for nitric oxide and interleukin 1β production. J. Biol. Chem. 277, 9077-9087.
31. Ruano, M. J., Hernandez-Hernando, S., Jimenez, A., Estrada, C., Villalobo, A. (2003) Nitric oxide-induced epidermal growth factor-dependent phosphorylations in A431 tumour cells. Eur. J. Biochem. 270, 1828-1837.
32. Ridley, A. J. (2001) Rho proteins, PI 3-kinases, and monocyte/macrophage motility. FEBS Lett. 498, 168-171.
33. Nobes, C. D., Hawkins, P., Stephens, L., Hall, A. (1995) Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J. Cell Sci. 108, 225-233.
34. Nobes, C. D., Hall, A. (1995) Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81, 53-62.
35. Song, Y., Hoang, B. Q., Chang, D. D. (2002) ROCK-II-induced membrane blebbing and chromatin condensation require actin cytoskeleton. Exp. Cell Res. 278, 45-52.
36. Coleman, M. L., Sahai, E. A., Yeo, M., Bosch, M., Dewar, A., Olson, M. F. (2001) Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3, 339-345.
37. Aktories, K. (1997) Bacterial toxins that target Rho proteins. J. Clin. Invest. 99, 827-829.
38. Wilson, H. L., Wilson, S. A., Surprenant, A., North, R. A. (2002) Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus. J. Biol. Chem. 277, 34017-34023.
39. Sauzeau, V., Le Jeune, H., Cario-Toumaniantz, C., Vaillant, N., Gadeau, A. P., Desgranges, C., Scalbert, E., Chardin, P., Pacaud, P., Loirand, G. (2000) P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes. Am. J. Physiol. Heart Circ. Physiol. 278, H1751-H1761.
40. Idzko, M., Dichmann, S., Ferrari, D., Di Virgilio, F., la Sala, A., Girolomoni, G., Panther, E., Norgauer, J. (2002) Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood 100, 925-932.
41. Pubill, D., Dayanithi, G., Siatka, C., Andres, M., Dufour, M. N., Guillon, G., Mendre, C. (2001) ATP induces intracellular calcium increases and actin cytoskeleton disaggregation via P2x receptors. Cell Calcium 29, 299-309.
42. Parker, K. E. (1998) Modulation of ATP-gated non-selective cation channel (P2X1 receptor) activation and desensitization by the actin cytoskeleton. J. Physiol. 510, 19-25.
43. Schilling, W. P., Sinkins, W. G., Estacion, M. (1999) Maitotoxin activates a nonselective cation channel and a P2Z/P2X(7)-like cytolytic pore in human skin fibroblasts. Am. J. Physiol. 277, C755-C765.
44. Sheng, M., Pak, D. T. (2000) Ligand-gated ion channel interactions with cytoskeletal and signaling proteins. Annu. Rev. Physiol. 62, 755-778.
45. Huot, J., Houle, F., Rousseau, S., Deschesnes, R. G., Shah, G. M., Landry, J. (1998) SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis. J. Cell Biol. 143, 1361-1373.
46. Landry, J., Huot, J. (1995) Modulation of actin dynamics during stress and physiological stimulation by a signaling pathway involving p38 MAP kinase and heat-shock protein 27. Biochem. Cell Biol. 73, 703-707.
47. Gendron, F. P., Neary, J. T., Theiss, P. M., Sun, G. Y., Gonzalez, F. A., Weisman, G. A. (2003) Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am. J. Physiol. Cell Physiol. 284, C571-C581.
48. Vemuri, G. S., Zhang, J., Huang, R., Keen, J. H., Rittenhouse, S. E. (1996) Thrombin stimulates wortmannin-inhibitable phosphoinositide 3-kinase and membrane blebbing in CHRF-288 cells. Biochem. J. 314, 805-810.
49. Aepfelbacher, M., Essler, M., Huber, E., Czech, A., Weber, P. C. (1996) Rho is a negative regulator of human monocyte spreading. J. Immunol. 157, 5070-5075.
50. Aepfelbacher, M. (1995) ADP-ribosylation of Rho enhances adhesion of U937 cells to fibronectin via the α 5 β 1 integrin receptor. FEBS Lett. 363, 78-80.
51. Ishizaki, T., Uehata, M., Tamechika, I., Keel, J., Nonomura, K., Maekawa, M., Narumiya, S. (2000) Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol. Pharmacol. 57, 976-983.
52. Wang, P., Bitar, K. N. (1998) Rho A regulates sustained smooth muscle contraction through cytoskeletal reorganization of HSP27. Am. J. Physiol. 275, G1454-G1462.
53. DeFife, K. M., Jenney, C. R., Colton, E., Anderson, J. M. (1999) Disruption of filamentous actin inhibits human macrophage fusion. FASEB J. 13, 823-832.
54. Jahraus, A., Egeberg, M., Hinner, B., Habermann, A., Sackman, E., Pralle, A., Faulstich, H., Rybin, V., Defacque, H., Griffiths, G. (2001) ATP-dependent membrane assembly of F-actin facilitates membrane fusion. Mol. Biol. Cell 12, 155-170.
55. Fairbairn, I. P., Stober, C. B., Kumararatne, D. S., Lammas, D. A. (2001) ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. J. Immunol. 167, 3300-3307.